Want to see SVA full AI Analyst Report?
Ev71 Vaccine
Ev71 Vaccine
Phase IV
Completed
Clinical Trial for Batch Consistency of EV71 Vaccine
Jun 10, 2025
―
Low-Dose Of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), Medium-Dose Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), High-Dose Tetravalent Inactivated Enterovirus Vaccine (Vero Cell) ), Ev71 Inactivated Enterovirus Vaccine (Vero Cell) )(For Ages 6-71 Months）
Hand, Foot, And Mouth Disease (Hfmd), Herpangina
Phase I/II
Not Yet Recruiting
Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
Dec 22, 2024
Sipv, Mmr, Hepa-I
Poliomyelitis
Phase IV
Completed
Booster Dose of sIPV Co-administered With MMR and HepA-I.
May 29, 2024
―
Sipv
Poliomyelitis
Phase IV
Completed
Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Different Manufacturers
Jan 29, 2024
―
Quadrivalent Influenza Vaccine, Trivalent Influenza Vaccine
Seasonal Influenza
Phase III
Completed
A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
Sep 15, 2023
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Sinovac Biotech (SVA) have in its pipeline
SVA is currently developing the following drugs: Participants Will Receive One Dose Of Vaccine (0.5 Ml) Of Sinovac Qiv, Vaxigrip Qiv, Ev71 Vaccine, Rabies Vaccine, Verorab. These drug candidates are in various stages of clinical development as the company works toward FDA approval.